Dr Juliana de Oliveira Costa
Lecturer
PhD (Public Health) - Federal University of Minas Gerais, 2019
MPH (Master by Research)听- Federal University of Minas Gerais, 2014
BPharm听(Pharmacy)听- Federal University of Minas Gerais, 2009
Medicine & Health
School of Population Health
I am an emerging leader in pharmacoepidemiology听researching听how medicines are used in populations, the consequences of their use and policies governing equitable access to medicines. My research aims to improve the quality use of medicines and, thereby, quality of life for people living with physical and mental health conditions.听听
I am a pharmacist by training with a background in public health and health technology assessment working in the Medicines Intelligence (MedIntel) Research Program at the School of鈥疨opulation Health. I have a strong focus on HIV, cardiometabolic and mental health medicines for treatment and prevention of health events.鈥疢y research investigates the patterns of use of medicines in the population, including treatment adherence, prescriber behaviour, and inappropriate use of medicines using data collected in routine clinical care. Previously, I have led and contributed to projects assessing a range of other medicine classes and, more broadly, projects evaluating other health technologies such as vaccines and medical procedures.
My research provides the evidence鈥痭eeded to inform clinical guidelines and鈥痯harmaceutical policy, and I often partner with clinicians and policymakers in my work. I am an enthusiastic leader of initiatives for capacity building and I supervise doctoral and masters鈥 candidates while also contributing to 麻豆社madou and the broader academic community.听
听
E-mail
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
Heart Foundation 2022 45 & Up Grant (ID:107048; $70,000) 鈥淣ovel antidiabetic medicines in NSW adults with Type II Diabetes: disparities in the uptake, guideline adherence and treatment persistence鈥 (CIA)
Cardiac, Vascular and Metabolic Medicine Theme 2023 鈥 Collaborative Grant听Grant Award 2023 ($30,000) 鈥淚mproving the use of cardiometabolic medicines in type 2 diabetes: an atlas to identify areas of unmet clinical need鈥澨(CIA)
NHMRC Partnership Project (ID:2007402; $1,216,847) 鈥淚dentifying the predictors and consequences of disparities in the uptake of HIV prevention and treatment programs in Australia: a national data linkage study鈥 (Associate Investigator)
听
2022, Young Investigator Prize - School of Population Health, 麻豆社madou Sydney 听
2022, Lenita Wannmacher National Award for Promoting the Quality Use of Medicines (Master by Research Category, Team member) - Brazilian Ministry of Health 听
2020, Best Paper by a PhD Candidate (Highly Commended) - 听Health Services Research Association of Australian and New Zealand 听
2020, Best PhD thesis - Postgraduate Program in Public Health, UFMG 听
2020, AIDS 2020: Virtual Scholarship Programme - International AIDS Society 听
2019, Spotlight Poster Winner - 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management 听
2018, Endeavour Research Fellowship - Department of Education and Training, Australian Government 听
2018, Visiting Student Scholarship - CAPES Foundation
My research has contributed substantially to improve the quality use of medicines and to inform policymaking. The听quality of my work is recognised by publication in top quartile journals, presentations at international conferences, awards, scholarships, and co-supervision of an HDR student and over 300 citations. 听I work collaboratively and contributed to creating听new collaborations hubs across 麻豆社madou research centres, including the Kirby Institute and the Centre for Primary Health Care and Equity.
Membership
- Health Services Research Association of Australia and New Zealand (2020 to date)
- International AIDS Society (2020 to date)
- ISPOR Student and ECR Chapter (2018 to date)
- Brazilian Association of Public Health [Associa莽茫o Brasileira de Sa煤de Coletiva 鈥 ABRASCO] 鈥 (2017 to date)
Peer review of manuscripts (See for further details)
- Frontiers in Pharmacoepidemiology (Jun 2020 to date)听
- Journal of Comparative Effectiveness Research (Jan 2020 to date)听
- Patient Related Outcomes Measures (Dec 2019 to date)听
- Applied Research in Quality of Life (Oct 2019 to date)听
- Revista de Psiquiatria Cl铆nica (Oct 2019 to date)听
- Frontiers in Public Health (Jun 2019 to date)听
- Revista de Sa煤de P煤blica (Apr 2019 to date)听
- International Journal of STD and AIDS (Mar 2019 to date)听
- European听Journal听of听Clinical听Pharmacology (Jul 2018 to date)听
- Ci锚ncia & Sa煤de Coletiva (Oct 2016 to date)听
Organising committee co-leader
- Capacity Building and Training, Medicines Intelligence CRE (2021 to date)
- CBDRH Research meetings (2020 to 2022)
Collaboration with external partners
- NPS MedicineWise听
- International researchers from Brazil (UFMG), Scotland (University of Strathclyde) and Canada (McGill University)
My Research Supervision
I have previously supervised to completion:
- One PhD in Medicines and Pharmaceutical Policy (joint supervisor)听
- Three Masters of Health Data Science students (primary and co-supervisor)
- Two Honours / Independent Learning Project students (co-supervisor)
My Teaching
My teaching interests combine the areas of pharmacoepidemiology, public health and听health economics听to provide the population with medicines and other health interventions that are effective, safe and affordable.
I previously taught听in HDAT9100 - Context of Health Data Science (Chapter instructor, 2020 - 2022), and taught Pharmacoepidemiology, Community Pharmacy and Professional Practice (UFMG).